← 返回

肿瘤周围脂肪组织通过脂肪-间充质转化驱动结直肠癌的免疫逃逸

英文原题:Peritumoural adipose tissue drives immune evasion in colorectal cancer via adipose-mesenchymal transformation.

查看英文原题

Peritumoural adipose tissue drives immune evasion in colorectal cancer via adipose-mesenchymal transformation.

PubMed 2026/02/19(内容时间) Nat Cell Biol Q1 · IF 22.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

尽管瘤周内脏脂肪组织(tVAT)在解剖学上与结直肠癌等肿瘤相邻,但该组织的免疫景观及其对肿瘤免疫的功能性贡献仍不明确。在此,我们对结直肠癌患者的tVAT进行了单细胞RNA分析,以绘制其免疫景观,并观察到tVAT呈现出高度免疫浸润的微环境,富含淋巴细胞,尤其是肿瘤特异性CD8⁺ T细胞。在机制上,tVAT通过激活CXCL12-CXCR4轴与肿瘤竞争这些免疫细胞,从而促进肿瘤免疫逃逸。此外,肿瘤来源因子诱导脂肪-间充质转化过程,其中脂肪基质细胞转分化为脂肪来源的癌症相关成纤维细胞,后者在tVAT中分泌大量CXCL12。在临床上,靶向脂肪-肿瘤相互作用显著增强了抗PD-1治疗的诊断和治疗疗效。这些发现有助于理解tVAT与肿瘤免疫逃逸之间的动态串扰,并突出tVAT作为癌症免疫治疗的潜在靶点。

展开英文摘要原文

Although peritumoural visceral adipose tissue (tVAT) is anatomically close to tumours such as colorectal cancer, the immune landscape of this tissue and its functional contribution to tumour immunity remain poorly defined.

Here, we performed single-cell RNA analysis on the tVAT from patients with colorectal cancer to map its immune landscape and observed that tVAT exhibited a highly immune-infiltrated microenvironment enriched with lymphocytes, especially tumour-specific CD8⁺ T cells.

Mechanistically, tVAT competes with the tumour for these immunocytes by activating the CXCL12-CXCR4 axis to promote tumour immune escape.

Moreover, tumour-derived factors induce an adipose-mesenchymal transformation process where the adipose stromal cells trans-differentiated into adipose-derived cancer-associated fibroblasts, which secrete large amounts of CXCL12 in tVAT. Clinically, targeting adipose-tumour interaction substantially enhances diagnostic and therapeutic efficacy of anti-PD-1 therapy.

These findings offer an understanding of the dynamic crosstalk between tVAT and tumour immune escape, highlighting the tVAT as a potential target for cancer immunotherapy.

论文信息

作者
Wang JH、Zheng YQ、Qian ZY、Pan YQ、Tian T、Duan XT、Wang RB、Wang LY
第一作者单位
State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.China
通讯作者单位
State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China. juhq@sysucc.org.cn.China
期刊
Nature cell biology2026 Mar
原文标识
PubMed 41714703 · DOI 10.1038/s41556-026-01885-0